◇◇新语丝(www.xys.org)(xys5.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)◇◇

复旦大学教授的暴富术

作者：zhengyi

　　发现复旦大学附属肿瘤医院的多名教授在SCI杂志大量发表META分析，有的
一年发表10几篇。影响因子高达60、70分。按照一分1万五的奖励，可以暴富了。

　　这其中有复旦大学附属肿瘤医院的胡夕春教授和邵志敏教授，是长江学者。
不知发表META分析有什么诀窍没有，作为论著一年发表如此之多，让人奇异。

2010年度肿瘤内科SCI论文汇总---共计29篇

SCI收录论文 

Qiu LX, Zhang J, Zhu XD, Zheng CL, Sun S, Wang ZH, Zhao XM, Wang JL, Wang LP, Yu H, Xue K, Hu XC
 邱立新
 The p21 Ser31Arg polymorphism and breast cancer risk: a meta-analysis involving 51,236 subjects
 Breast Cancer Res Treat
 2010
 124
 2
 475-9
 
Qiu LX, Yao L, Zhang J, Zhu XD, Zhao XM, Xue K, Mao C, Chen B, Zhan P, Yuan H, Hu XC
 邱立新
 XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects
 Breast Cancer Res Treat
 2010
 124
 1
 229-35
 
Qiu LX, Yao L, Mao C, Chen B, Zhan P, Yuan H, Xue K, Zhang J, Hu XC
 胡夕春
 Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects
 Breast Cancer Res Treat
 2010
 123
 2
 543–547
 
Qiu LX, Yao L, Mao C, Chen B, Zhan P, Xue K, Zhang J, Yuan H, Hu XC
 胡夕春
 TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects
 Breast Cancer Res Treat
 2010
 123
 2
 563–567
 
Qiu LX, Yao L, Xue K, Zhang J, Mao C, Chen B, Zhan P, Yuan H, Hu XC
 胡夕春
 BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects
 Breast Cancer Res Treat
 2010
 123
 2
 487–490
 
Qiu LX, Yao L, Yuan H, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC
 胡夕春
 IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls
 Breast Cancer Res Treat
 2010
 122
 3
 867-871
 
Qiu LX, Yao L, Mao C, Yu KD, Zhan P, Chen B, Yuan H, Zhang J, Xue K, Hu XC
 胡夕春
 Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects
 Breast Cancer Res Treat
 2010
 122
 2
 521-525
 
Qiu LX, Mao C, Yao L, Yu KD, Zhan P, Chen B, Liu HG, Yuan H, Zhang J, Xue K, Hu XC
 胡夕春
 XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer  susceptibility: a meta-analysis
 Breast Cancer Res Treat
 2010
 122
 2
 489-493
 
Qiu LX, Chen B, Mao C, Zhan P, Yuan H, Xue K, Hu XC
 胡夕春
 Glutathione S-transferase M1 (GSTM1) polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects
 Breast Cancer Res Treat
 2010
 121
 3
 703-708
 
Zhang J, Hu XC, Liu XJ, et al
 洪小南
 Prognostic Factors in Primary Gastric non-Hodgkin’s Lymphoma - a Single-Center Retrospective Analysis of 103 Cases from China
 Hepato-Gastroenterol
 2010
 57
  
 1-6
 
Zhang J, Qiu LX, Wang ZH, et al..
 胡夕春
 MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls
 Breast Cancer Res Treat
 2010
 123
  
 549-55
 
Zhang J, Qiu LX, Wang ZH, Wang JL, He SS, Hu XC
 胡夕春
 NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis
 Breast Cancer Res Treat
 2010
 123
  
 877-83
 
hang J, Qiu LX, Wang ZH, et al
 胡夕春
 Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis
 Breast Cancer Res Treat
 2010
 124
 2
 419-24
 
Zhang J, Gu SY, Zhang P, Jia Z, Chang JH
 常建华
  ERCC2 Lys751Gln polymorphism is associated with lung cancer among Caucasians
 Eur J Cancer
 2010
 46
  
 2479-84
 
Zhao X, Xu X, Guo L, Ragaz J, Guo H, Wu J, Shao Z, Zhu J, Guo X, Chen J, Zhu B, Wang Z, Hu X
 胡夕春
 Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance
 Breast Cancer Res Treat
 2010
 124
 3
 733-43
 
(XYS20110609)

◇◇新语丝(www.xys.org)(xys5.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)◇◇